⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
FTRE News
Fortrea Holdings Inc. Common Stock
Fortrea Announces Date for First Quarter 2026 Financial Results and Conference Call
globenewswire.com
FTRE
Redefining Hematologic Malignancy Drug Development: How Molecular Reclassification, MRD, & AI is Reshaping Precision Hematology, Upcoming Webinar Hosted by Xtalks
prnewswire.com
NEO
FTRE
Fortrea 推出 Fortrea Intelligent Technology™，助力申办方和研究中心开展更智能、更协同的临床试验
globenewswire.com
FTRE
Bronstein, Gewirtz & Grossman, LLC Is Investigating Fortrea Holdings, Inc. (FTRE) And Encourages Shareholders to Connect
accessnewswire.com
FTRE
Fortrea Unveils Fortrea Intelligent Technology™ to Help Sponsors and Sites Run Smarter, More Integrated Trials
globenewswire.com
FTRE
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Fortrea Holdings, Inc. (FTRE) And Encourages Shareholders to Reach Out
accessnewswire.com
FTRE
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Fortrea Holdings, Inc. (FTRE) and Encourages Shareholders to Learn More About the Investigation
accessnewswire.com
FTRE
Fortrea Holdings, Inc. (FTRE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation
accessnewswire.com
FTRE
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Fortrea Holdings, Inc. (FTRE) and Encourages Investors to Learn More About the Investigation
accessnewswire.com
FTRE
Fortrea Holdings, Inc. (FTRE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation
accessnewswire.com
FTRE